C-Peptide Measurement and its Clinical Usefulness: A Review

Steiner DF Oyer PE. The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma. Proc Natl Acad Sci USA 1967: 56: 473–80.

Chance RE Ellis RM Bromer WW. Porcine proinsulin: characterization and amino acid sequence. Science 1968; 161: 165–7.

Clark JL Cho S Rubenstein AH Steiner DF Isolation of a proinsulin connecting peptide fragment (C-peptide) from bovine and human pancreas. Biochem Biophys Res Comm 1969; 35: 456–61.

Steiner DF. Proinsulin. Triangle 1972; 11: 51–60.

Lacy PE. β-cell secretion from the standpoint of a pathobiologist. Diabetes 1970; 19: 895–905.

Sorensen RL Steffes MW Lindall AW. Subcellular localization of proinsulin to insulin conversion in isolated rat islets. Endocrinology 1970; 86: 88–96.

Kemmler W Peterson JD Steiner DF. Studies on the conversion of proinsulin to insulin. I-Conversion in vitro with trypsin and carboxypeptidase B. J Biol Chem 1971; 246: 6786–91.

Rubenstein AH Clark JL Melani F Steiner DF. Secretion of proinsulin C-peptide by pancreatic β cells and its circulation in blood. Nature (London) 1969; 224: 697–9.

Horwitz DL Starr JI Mako ME Blackard WG Rubenstein AH. Proinsulin, insulin and C-peptide concentrations in human portal and peripheral blood. J Clin Invest 1975; 55: 1278–83.

Heding LG Rasmussen S. Munkgaard Human C-peptide in normal and diabetic subjects. Diabetologia 1975; 11: 201–6.

Rubenstein AH Kuzuya MD Horwitz DL. Clinical significance of circulating C-peptide in diabetes mellitus and hypoglycemic disorders. Arch Intern Med. 1977; 137: 625–32.

Kitabchi AE. Proinsulin and C-peptide: a review. Metabolism 1977; 26: 547–87.

Steiner DF. On the role of the proinsulin C-peptide. Diabetes 1978: 28 (suppl 1): 145–8.

Rubenstein AH Welbourne WP Mako M Melani F Steiner DF. Comparative immunology of bovine, porcine and human proinsulins and C-peptides. Diabetes 1970; 19: 546–53.

Kuzuya H Chance RE Steiner DF Rubenstein AH. On the preparation and characterization of standard materials for natural human proinsulin and C-peptide. Diabetes 1978; 27 (suppl 1): 161–9.

Melani F Rubenstein AH Oyer PE Steiner DF. Identification of proinsulin and C-peptide in human serum by specific immunoassay. Proc Natl Acad Sci USA 1970; 67: 148–55.

Yanaihara N Yanaihara C Sakagami M Sakura N Hashimoto T Nishida T. Syntheses of C-peptides and human proinsulin. Diabetes 1978; 27 (suppl 1): 149–60.

Kuzuya H. Blix PM Horwitz DL Rubenstein AH Steiner DF Faber OK Binder C. Heterogeneity of circulating human C-peptide. Diabetes 1978; 27 (suppl 1): 184–91.

Kaneko T Oka H Munemura M Oda T Yamashita K Suzuki S Yanaihara N Hashimoto T Yanaihara C. Radioimmunoassay of human proinsulin C-peptide using synthetic human connecting peptide. Endocrinol Japon 1974; 21: 141–5.

Horwitz DL Rubenstein AH Steiner DF. Proinsulin and C-peptide in diabetes. Med Clin North Am 1978; 62: 723–33.

Faber OK Binder C Markussen J Heding LG Naithani VK Kuzuya H Blix P Horwitz DL Rubenstein AH. Characterization of seven C-peptide antisera. Diabetes 1978; 27 (suppl 1): 170–7.

Heding LG. Radioimmunological determination of human C-peptide in serum. Diabetologia 1975; 11: 541–8.

Gorden P Hendricks CM Roth J. Circulating proinsulin-like component in man-increased proportion in hypoinsulinemia states. Diabetologia 1974; 11: 469–74.

Turner RC Heding LG. Plasma proinsulin, C-peptide and insulin in diagnostic suppression tests for insulinomas. Diabetologia 1977; 13: 351–7.

Duckworth WC Kitabchi AE Heinemann M. Direct measurement of plasma proinsulin in normal and diabetic subjects. Am J Med. 1972; 53: 418–27.

Gabbay KH DeLuca K Fisher JN Jnr Mako ME Rubenstein AH. Familial hyperproinsulinemia: an autosomal dominant defect. N Eng J Med. 1976; 294: 911–5.

Heding LG. Insulin, C-peptide and proinsulin in non-diabetics and insulin-treated diabetics: characterization of the proinsulin in insulin treated diabetics. Diabetes 1978; 27 (suppl 1): 178–83.

Roth J Gordon P Pastan I. “Big Insulin”: a new component of plasma insulin detected by immunoassay. Proc Natl Acad Sci USA 1968; 61: 138–45.

Rubenstein AH Steiner DF Horwitz DL Mako ME Block MB Starr JI Kuzuya H Melani F. Clinical significance of circulating proinsulin and C-peptide. Rec Prog Homn Res. 1977; 33: 435–75.

Kitabchi AE Duckworth WC Brush JS Heinemann M. Direct measurement of proinsulin in human plasma by the use of a insulin degrading enzyme. J Clin Invest 1971; 50: 1792–9.

Starr JI Juhn DD Rubenstein AH Kitabchi AE. Degradation of insulin in serum by insulin-specific protease. J Lab Clin Med. 1975; 86: 631–7.

Kuzuya H Blix P Horwitz DL Steiner DF Rubenstein AH. Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 1977; 26: 22–9.

Garcia-Webb P Bonser A. Decrease in measured C-peptide immunoreactivity on storage. Clin Chim Acta 1979; 95: 139–41.

Garcia-Webb P Bonser A Wearne KL Gracey M. Obesity and insulin secretion in fasting high school students. Diabetologia 1980; 19: 194–7.

Block MB Mako ME Steiner DF Rubenstein AH. Circulating C-peptide immunoreactivity. Studies in normals and diabetic patients. Diabetes 1972; 21: 1013–26.

Ludvigsson J Heding LG. β-cell function in children with diabetes. Diabetes 1978; 27 (suppl 1): 230–4.

Hendriksen C Faber OK Drejer J Binder C. Prevalence of residual β-cell function in insulin-treated diabetics evaluated by the plasma C-peptide response to intravenous glucagon. Diabetologia 1977; 13: 615–9.

Grajwer LA Pildes RS Horwitz DL Rubenstein AH. Control of juvenile diabetes mellitus and its relationship to endogenous insulin secretion as measured by C-peptide immunoreactivity. J Pediatr 1977; 90: 42–8.

Sherwin R Felig P. Pathophysiology of diabetes mellitus. Med Clin North Am 1978; 62: 695–711.

Heding LG. Specific and direct radioimmunoassay for human proinsulin in serum. Diabetologia 1977; 13: 467–74.

Beischer W Kerner W Raplis S Keller L Beischer B Pfeiffer EF. Insulin therapy in relation to circulating C-peptide levels. Diabetes 1978; 27 (suppl 1): 235–40.

Turner RC Johnson PC. Suppression of insulin release by fish insulin induced hypoglycemia. Lancet 1973; 1: 1483–5.

Service FJ Horwitz DL Rubenstein AH Kuzuya H Mako M Reynolds C Molnar GD. C-peptide suppression test for insulinoma. J Lab Clin Med. 1977: 90: 180–6.

Couropmitree C Freinkel N Nagel TC Horwitz DL Metzger B Rubenstein AH Hahnel R. Plasma C-peptide and diagnosis of factitious hyperinsulinism. Ann Intern Med. 1975; 82: 201–4.

Block MB Pildes RS Mossabhoy NA Steiner DF Rubenstein AH. C-peptide immunoreactivity (CPR): A new method for studying infants of insulin-treated diabetic mothers. Pediatrics 1974; 53: 923–8.

Horwitz DL Rubenstein AH Mako ME Kruz A Blix DM. C-peptide in conditions other than diabetes mellitus. Diabetes 1978; 27 (suppl 1): 267–71.

Johnston DG Alberti KGMM Faber OK Binder C Wright R. Hyperinsulinism of hepatic cirrhosis: diminished degradation or hypersecretion. Lancet 1977; 1: 10–2.

Jaspan JB Mako ME Kuzuya H Blix PM Horwitz DL Rubenstein AH. Abnormalities in circulating (β-cell peptides in chronic renal failure: Comparison of C-peptide, proinsulin and insulin. J Clin Endo Metab 1977; 45: 441–6.

Horwitz DL Rubenstein AH Katz AI. Quantitation of human pancreatic β-cell function by immunoassay of C-peptide in urine. Diabetes 1977; 26: 30–5.

Kuzuya T Matsuda A Sakamoto Y Tanabshi S Kajinuma H. C-peptide immunoreactivity (CPR) in urine. Diabetes 1978; 27 (suppl 1): 210–5.

Kaneko T Munemura M Oka H Oda T Suzuki S Yasuda H Yanaihara N Nakagawa S Makabe K. Demonstration of C-peptide immunoreactivity in various body fluids, and clinical evaluation of the determination of urinary C-peptide immunoreactivity. Endocrinol Japon 1975; 22: 207–12.

Kuzuya T Matsuda A Saito T Yoshida S. Human C-peptide immunoreactivity (CPR) in blood and urine—evaluation of a radioimmunoassay method, and its clinical applications. Diabetologia 1976; 12: 511–8.